Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Zigeuner

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
European Urology|September 5, 2017
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
BJU International|January 23, 2014
Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasisThomas Seisen, Pierre Colin, Vincent Hupertan, et al.
Urologic Oncology|May 27, 2018
Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohortGiancarlo Marra, Paolo Gontero, Michele Brattoli, et al.
The Journal of Urology|July 13, 2010
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tractVitaly Margulis, Ramy F Youssef, Pierre I Karakiewicz, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
BJU International|October 3, 2007
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Claudio Jeldres, et al.
European Urology|June 22, 2016
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016Marko Babjuk, Andreas Böhle, Maximilian Burger, et al.
Cancer|October 7, 2005
Proposal for revision of the TNM classification system for renal cell carcinomaVincenzo Ficarra, François Guillè, Luigi Schips, et al.
Journal of Endourology|March 11, 2011
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinomaCenk Gurbuz, Ramy F Youssef, Shahrokh F Shariat, et al.
European Urology Focus|November 25, 2018
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines PanelViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
European Urology|September 5, 2017
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
BJU International|January 23, 2014
Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasisThomas Seisen, Pierre Colin, Vincent Hupertan, et al.
Urologic Oncology|May 27, 2018
Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohortGiancarlo Marra, Paolo Gontero, Michele Brattoli, et al.
The Journal of Urology|July 13, 2010
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tractVitaly Margulis, Ramy F Youssef, Pierre I Karakiewicz, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
BJU International|October 3, 2007
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Claudio Jeldres, et al.
European Urology|June 22, 2016
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016Marko Babjuk, Andreas Böhle, Maximilian Burger, et al.
Cancer|October 7, 2005
Proposal for revision of the TNM classification system for renal cell carcinomaVincenzo Ficarra, François Guillè, Luigi Schips, et al.
Journal of Endourology|March 11, 2011
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinomaCenk Gurbuz, Ramy F Youssef, Shahrokh F Shariat, et al.
European Urology Focus|November 25, 2018
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines PanelViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
Pageof 17